Table 4. Univariate and multivariate analyses for the predictor of progression to CRPC using genetic analysis.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age, yr | 0.959 (0.919–1.000) | 0.050 | 1.016 (0.951–1.084) | 0.644 |
PSA | 1.001 (1.001–1.002) | < 0.001 | 1.000 (0.998–1.001) | 0.815 |
Biopsy Gleason score | ||||
6 | ref | ref | ||
7 | 0.384 (0.024–6.177) | 0.500 | 0.457 (0.028–7.531) | 0.584 |
8 | 6.483 (0.870–48.299) | 0.068 | 7.670 (0.932–63.088) | 0.058 |
rs2241714 | 0.516 (0.246–1.084) | 0.081 | 1.702 (0.572–5.066) | 0.339 |
rs143790069 | 1.590 (0.600–4.214) | 0.351 | 0.666 (0.163–2.730) | 0.573 |
rs72821581 | 1.573 (0.475–5.214) | 0.459 | 1.170 (0.283–4.837) | 0.828 |
rs75992542 | 1.593 (0.644–3.945) | 0.314 | 2.825 (0.685–11.656) | 0.151 |
rs56350726 | 2.734 (1.215–6.155) | 0.015 | 4.172 (1.223–14.239) | 0.023 |
Multivariate Cox model including Age, PSA, biopsy Gleason score, rs2241714, rs143790069, rs72821581, rs75992542, rs56350726